BioSpace News Archive

Deals

Invitation to the presentation of Recipharm’s interim report January - March 2019

Recipharm AB will publish its interim report for January-March 2019 on 3 May at 07:45 am CET.

May 1, 2019
·
1 min read
Business

Codexis Signs Multi-Year Enzyme Supply and Licensing Agreement with Tate & Lyle for the Manufacture of TASTEVA® M Stevia Sweetener

Codexis’ breakthrough enzyme cascade system enables better-tasting stevia product launch

May 1, 2019
·
4 min read
Deals

Auris Medical Announces Reverse Stock Split

Auris Medical Holding Ltd. announced that its Board of Directors has approved a reverse stock split of its common shares at a ratio of 1-for-20.

May 1, 2019
·
6 min read
Drug Development

Clinical Trial Results from MyoKardia’s Phase 2 PIONEER-HCM Study of Mavacamten Published in the Annals of Internal Medicine

Clinical Trial Results from MyoKardia’s Phase 2 PIONEER-HCM Study of Mavacamten Published in the Annals of Internal Medicine

May 1, 2019
·
11 min read
Deals

Karolinska Development publishes its Annual Report for 2018 with an update on the financial situation

Karolinska Development AB has published its Annual Report for 2018.

May 1, 2019
·
5 min read
Deals

Polarean Imaging Plc Total Voting Rights

Polarean Imaging announces that the total number of shares in issue and total voting rights as at the date of this announcement is 101,435,933 ordinary shares of £0.00037 each.

May 1, 2019
·
1 min read
Policy

Christiana Care’s Gene Editing Institute takes the next step toward its first investigational drug application for FDA approval to treat lung cancer using CRISPR

Gene Editing Institute’s study will be a novel investigation of the use of CRISPR technology to treat K-ras-positive non-small cell lung cancer

May 1, 2019
·
3 min read
Business

Arcutis, Inc. Announces Board of Directors

Board Comprised of Leading Dermatology Experts and Lifescience Investors

May 1, 2019
·
2 min read
Deals

Omni Health Inc Possible Reverse Merger With LX Retail Group, LLC

UndergroundStocks.com, an elite wall street independent small cap media group with a history of bringing lucrative opportunities, Reports on Omni Health, Inc.

May 1, 2019
·
4 min read
Deals

GENFIT: Reports First quarter 2019 Financial Information

Following the capital increase and listing on Nasdaq, cash and cash equivalents totaled €314.1 million as of March 31, 2019

May 1, 2019
·
3 min read